» Articles » PMID: 10378622

Risk Factors Associated with Symptoms of Gastroesophageal Reflux

Overview
Journal Am J Med
Specialty General Medicine
Date 1999 Jun 23
PMID 10378622
Citations 128
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although patients with gastroesophageal reflux are often instructed to change their lifestyle, population-based data on the risk factors for reflux in the United States are lacking.

Methods: We performed a cross-sectional study in an age- and gender-stratified random sample of the population of Olmsted County, Minnesota. Residents aged 25 to 74 years were mailed a valid self-report questionnaire that measured reflux symptoms and potential risk factors. Logistic regression was used to estimate the odds ratios (OR) with 95% confidence intervals (CI) for reflux symptoms (heartburn or acid regurgitation) associated with potential risk factors.

Results: Overall, 1,524 (72%) of 2,118 eligible subjects responded. A body mass index >30 kg/m2 (OR = 2.8; CI, 1.7 to 4.5), reporting an immediate family member with heartburn or disease of the esophagus or stomach (OR = 2.6; CI, 1.8 to 3.7), a past history of smoking (OR = 1.6; CI, 1.1 to 2.3), consuming more than seven drinks per week (OR = 1.9; Cl, 1.1 to 3.3), and a higher psychosomatic symptom checklist score (OR per 5 units = 1.4; CI, 1.3 to 1.6) were independently associated with frequent (at least weekly) reflux symptoms.

Conclusion: Obesity is a strong risk factor for gastroesophageal reflux, although the value of weight reduction remains to be proven. That family history was also a risk factor suggests that there may be a genetic component to the disorder.

Citing Articles

Predictors of Pathological Gastroesophageal Reflux among Emirati Patients with Reflux Symptoms Who Undergo Wireless pH Monitoring.

Shehata M, Malik T, Alzaabi M, Ali A, Tenaiji K, Singh Y Middle East J Dig Dis. 2024; 15(4):242-248.

PMID: 38523885 PMC: 10955985. DOI: 10.34172/mejdd.2023.353.


Dental evaluation is helpful in the differentiation of functional heartburn and gastroesophageal reflux disease.

Helle K, Arok A, Olle G, Antal M, Rosztoczy A World J Gastroenterol. 2023; 29(31):4774-4782.

PMID: 37664156 PMC: 10473917. DOI: 10.3748/wjg.v29.i31.4774.


Emerging Role of GLP-1 Agonists in Obesity: A Comprehensive Review of Randomised Controlled Trials.

Popoviciu M, Paduraru L, Yahya G, Metwally K, Cavalu S Int J Mol Sci. 2023; 24(13).

PMID: 37445623 PMC: 10341852. DOI: 10.3390/ijms241310449.


Risk factors for adverse outcomes following paraesophageal hernia repair among obese patients.

Kanagasegar N, Alvarado C, Lyons J, Rivero M, Vekstein C, Levine I Surg Endosc. 2023; 37(9):6791-6797.

PMID: 37253871 DOI: 10.1007/s00464-023-10115-9.


Prevalence of Gastroesophageal Reflux Disease (GERD) Among Electronic Cigarette-Smoking University Students in Jeddah, Saudi Arabia.

Alturki N, Alghamdi R, Almehmadi R, Derar R, Waznah R, Niyazi R Cureus. 2023; 15(3):e35890.

PMID: 37033588 PMC: 10080981. DOI: 10.7759/cureus.35890.